Evidence map›Paper›PMID 26129757›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review.

Gustavo E Velásquez, Omowunmi Aibana, Emilia J Ling, Ibrahim Diakite, Eric Q Mooring, Megan B Murray

Abstract readSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Diagnostics of Ebola virus.Frontiers in public health · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The state of latency in microbial pathogenesis.The Journal of clinical investigation · 2020
    Review
  18. Ebola virus disease.Nature reviews. Disease primers · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gustavo E VelásquezDivisions of Infectious Diseases Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts.
Omowunmi AibanaGlobal Health Equity, Brigham and Women's Hospital Division of Infectious Diseases, Miriam Hospital, Providence, Rhode Island.
Emilia J LingDepartment of Epidemiology.
Ibrahim DiakiteDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Eric Q MooringDepartment of Epidemiology Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health.
Megan B MurrayDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts Department of Epidemiology Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2009 to 2018
$26.4M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
NIAID NIH HHS T32 AI007433NIAID NIH HHS T32 AI007535NIDA NIH HHS T32 DA013911NIGMS NIH HHS U54 GM088558
6 · The paper itself

Abstract

We systematically reviewed the literature to estimate the incubation and latent periods of Ebola virus disease. We found limited epidemiological data from individuals with discrete 1-day exposures. Available data suggest that the incubation and latent periods may differ, and mathematical models may be improved by distinguishing between the two periods.

Indexed as

EbolavirusHemorrhagic Fever, EbolaInfectious Disease Incubation PeriodHumansTime FactorsVirus LatencyEbolaincubation periodlatent periodsystematic reviewtransmission

Identifiers

PMID26129757
PMCPMC4560911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.